These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16678216)

  • 21. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic mechanisms in the basolateral amygdala differentially regulate the conditioned and unconditioned fear organized in the periaqueductal gray.
    Martinez RC; Ribeiro de Oliveira A; Brandão ML
    Eur Neuropsychopharmacol; 2007 Nov; 17(11):717-24. PubMed ID: 17398077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze.
    Zanoveli JM; Nogueira RL; Zangrossi H
    Neuropharmacology; 2007 Mar; 52(4):1188-95. PubMed ID: 17313964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: Involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray.
    Batistela MF; Vilela-Costa HH; Frias AT; Hernandes PM; Lovick TA; Zangrossi H
    J Psychopharmacol; 2021 Dec; 35(12):1523-1535. PubMed ID: 34872406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram.
    Schreiber S; Pick CG
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):464-8. PubMed ID: 16413173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin in the dorsal periaqueductal gray inhibits panic-like defensive behaviors in rats exposed to acute hypoxia.
    Spiacci A; Sergio Tde O; da Silva GS; Glass ML; Schenberg LC; Garcia-Cairasco N; Zangrossi H
    Neuroscience; 2015 Oct; 307():191-8. PubMed ID: 26319117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray.
    Lim LW; Blokland A; Tan S; Vlamings R; Sesia T; Aziz-Mohammadi M; Visser-Vandewalle V; Steinbusch HW; Schruers K; Temel Y
    Exp Neurol; 2010 Dec; 226(2):293-300. PubMed ID: 20837005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila.
    Dunham KE; Venton BJ
    J Neurochem; 2022 Sep; 162(5):404-416. PubMed ID: 35736504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.
    Zanoveli JM; Nogueira RL; Zangrossi H
    Behav Pharmacol; 2005 Nov; 16(7):543-52. PubMed ID: 16170231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.
    Massé F; Hascoët M; Bourin M
    Behav Brain Res; 2005 Oct; 164(1):17-28. PubMed ID: 16081166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Escitalopram--second generation of serotonin transporter inhibitors?].
    Rybakowski J; Borkowska AB
    Psychiatr Pol; 2004; 38(2):227-39. PubMed ID: 15307289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.
    Sánchez C; Gruca P; Papp M
    Behav Pharmacol; 2003 Sep; 14(5-6):465-70. PubMed ID: 14501259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity.
    Jenck F; Moreau JL; Martin JR
    Psychiatry Res; 1995 Jul; 57(2):181-91. PubMed ID: 7480384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze.
    Beijamini V; Andreatini R
    Pharmacol Res; 2003 Aug; 48(2):199-207. PubMed ID: 12798673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Panicolytic-like effect of BDNF in the rat dorsal periaqueductal grey matter: the role of 5-HT and GABA.
    Casarotto PC; de Bortoli VC; Corrêa FM; Resstel LB; Zangrossi H
    Int J Neuropsychopharmacol; 2010 Jun; 13(5):573-82. PubMed ID: 20047714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
    Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid CB
    Batista LA; Moreira FA
    Neurosci Lett; 2019 Jun; 703():5-10. PubMed ID: 30858018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shock priming enhances the efficacy of SSRIs in the foot shock-induced ultrasonic vocalization test.
    Kassai F; Gyertyán I
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):128-35. PubMed ID: 22041499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.